SureTrader SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 9/2/2015 10:18:56 PM - Followers: 1246 - Board type: Free - Posts Today: 0
PostSubject
#194737  Sticky Note Ariad and Baxalta can't agree on price. jbog 09/02/15 09:33:34 AM
#194736  Sticky Note NEO"NeoGenomics Enters into National Agreement with Premier, Inc. apljack 09/02/15 08:47:23 AM
#194735  Sticky Note Bmy is going full press in fibrosis. I dewophile 09/02/15 07:55:34 AM
#194729  Sticky Note AMGN, NVS ink AD/migraine drug-development collaboration: DewDiligence 09/01/15 04:35:34 PM
#194642  Sticky Note Brief musings on MON and The Global Demographic DewDiligence 08/26/15 04:07:16 PM
#194622  Sticky Note Why MNTA? MNTA obviously has several DewDiligence 08/25/15 05:37:40 PM
#194772   >>I would submit that 10b5-1 terminations when a biomaven0 09/02/15 10:18:56 PM
#194771   Re: 10b5-1 terminations when an acquisition (or other DewDiligence 09/02/15 09:05:25 PM
#194770   >>When two insiders failed to cancel their 10b5-1 biomaven0 09/02/15 08:31:38 PM
#194769   It appears that very soon almost everybody will caravon 09/02/15 05:57:38 PM
#194768   First, it had to be "entertainment". caravon 09/02/15 05:51:42 PM
#194767   Same product—i.e. Varubi was approved three days before DewDiligence 09/02/15 05:25:41 PM
#194766   TSRO has a PFUDA 9/5/15 or is this it...? jdc 09/02/15 05:23:26 PM
#194765   LCI +21%/AH on $1.2B acquisition of UCB’s US-generics subsidiary: DewDiligence 09/02/15 05:12:26 PM
#194764   Thoughts on BMSN/RGBP Anyone? MakeittoV221 09/02/15 04:39:19 PM
#194763   Webcast Calendar ghmm 09/02/15 03:57:57 PM
#194762   Even AGTC—(which is located in central Florida)—wants a DewDiligence 09/02/15 01:54:21 PM
#194761   FDA approves TSRO’s Varubi (rolapitant) for prevention of DewDiligence 09/02/15 01:52:00 PM
#194760   If NEO is not providing actual treatment recommendations DewDiligence 09/02/15 01:40:24 PM
#194759   So, NEO is not a competitor of FMI, apljack 09/02/15 01:35:04 PM
#194758   So, NEO is not a competitor of FMI, DewDiligence 09/02/15 01:22:43 PM
#194757   As a standalone product (for HBV), TAF will DewDiligence 09/02/15 01:19:01 PM
#194756   VRX acquires SURG for $6.50/sh in cash plus contingencies apljack 09/02/15 01:08:51 PM
#194755   So then, when will TAF be available commercially linhdtu 09/02/15 01:08:19 PM
#194754   Yes—TAF is in two phase-3 trials as a DewDiligence 09/02/15 01:01:01 PM
#194753   TrovaGene Looks To Revolutionize The Cancer Diagnostic Market CHM_760 09/02/15 12:57:59 PM
#194752   Dew, will TAF be available as a single linhdtu 09/02/15 12:53:21 PM
#194751   INCY in-licenses PD-1 drug candidate for $25M up-front DewDiligence 09/02/15 12:46:30 PM
#194750   SGMO -8% on SHPG’s dumping program in hemophilia A/B: DewDiligence 09/02/15 12:42:52 PM
#194749   BMY—PDUFA date for Opdivo in 2nd-line non-squamous NSCLC DewDiligence 09/02/15 12:39:20 PM
#194748   NEO vs. FMI apljack 09/02/15 12:12:25 PM
#194747   $LPCN ok I'm calling 20 by sept 14. whatisthecolorofmone 09/02/15 11:55:16 AM
#194746   MNTA/MYL/TEVA—USPTO IPR against all three 40mg-Copaxone patents in DewDiligence 09/02/15 11:07:59 AM
#194745   GILD’s F/TAF non-inferior to Truvada on efficacy at DewDiligence 09/02/15 11:00:30 AM
#194744   Recent Biotech Buyouts of Publicly Traded Companies DewDiligence 09/02/15 10:46:50 AM
#194743   VRX acquires SURG for $6.50/sh in cash plus DewDiligence 09/02/15 10:45:22 AM
#194741   PIRS moving corporate HQ from Germany to Boston: DewDiligence 09/02/15 10:28:30 AM
#194740   How does NEO's service compare to FMI's? DewDiligence 09/02/15 10:13:02 AM
#194739   ARIA—When two insiders failed to cancel their 10b5-1 DewDiligence 09/02/15 10:11:08 AM
#194738   MEIP reports fiscal year-end results bladerunner1717 09/02/15 10:00:38 AM
#194737   Ariad and Baxalta can't agree on price. jbog 09/02/15 09:33:34 AM
#194736   NEO"NeoGenomics Enters into National Agreement with Premier, Inc. apljack 09/02/15 08:47:23 AM
#194735   Bmy is going full press in fibrosis. I dewophile 09/02/15 07:55:34 AM
#194734   My bad—you did say, oral drug in your DewDiligence 09/01/15 06:00:21 PM
#194733   TRVN In the acute, in-hospital setting, which TRVN iwfal 09/01/15 05:57:31 PM
#194732   FLXN +8%/AH on FDA Fast Track designation for FX006: DewDiligence 09/01/15 05:40:59 PM
#194731   SNY dumps ARDX’s NaP2b program: DewDiligence 09/01/15 05:37:29 PM
#194730   Thanks for the info. I am long TGTX lgonber 09/01/15 05:30:39 PM
#194729   AMGN, NVS ink AD/migraine drug-development collaboration: DewDiligence 09/01/15 04:35:34 PM
#194728   TGTX potential positive? "Idelalisib is too toxic to kiroset 09/01/15 04:30:19 PM
#194727   About time. ilpapa 09/01/15 04:12:02 PM
#194726   The statement of the day: caravon 09/01/15 02:49:46 PM
#194725   TRVN—…I want to see better data on addiction DewDiligence 09/01/15 01:09:38 PM
#194724   TRVN The most consequential safety/tolerability issue is respiratory iwfal 09/01/15 12:51:06 PM
#194723   OT: Does anyone know of any experimental drugs iandy 09/01/15 12:12:40 PM
#194722   OCAT: MARLBOROUGH, Mass.--(BUSINESS WIRE)-- north40000 09/01/15 11:19:20 AM
PostSubject